Nicholas Leeper
Professor and Chair, UW Bioengineering · Stanford Health Care
Credentials: · · · ·
History
- Present
UW Bioengineering Department · Stanford Health Care
- Present
Stanford University Division · Stanford Health Care
- Present
Vascular Medicine/Vascular Surgery Division · Stanford Health Care
- 2005–2008
Cardiovascular Disease
- 1995–1999
Research
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Nature · 2016 · Last of 18 authors · 580 citations
Arteriosclerosis · 2019 · 311 citations
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis
Journal of Clinical Investigation · 2008 · 294 citations
24 papers · 10 as a resident
20 papers
- SA
18 papers · 18 as a resident
14 papers · 4 as a fellow
14 papers
12 papers · 7 as a fellow
10 papers
10 papers · 8 as a fellow
Grants
- 2025–2032
The Role of Cancer in Cardiovascular Disease
National Heart, Lung, and Blood Institute · R35
Contact PI · $2.2M · Stanford University
- 2010–2030
T32 Training Program in Mechanisms and Innovation in Vascular Disease
National Heart, Lung, and Blood Institute · T32
PI · $3.8M · Stanford University
- 2019–2025
Clonal Expansion, Resistance to Efferocytosis and Innate Immunity in Atherosclerosis
National Heart, Lung, and Blood Institute · R35
Contact PI · $5.1M · Stanford University
- 2014–2019
The Paradoxical Role of CDKN2B in Blood Vessel Sprouting and Maturation
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.9M · Stanford University
Clinical trials
- 2013–2014
Effect of Proton Pump Inhibitors on Endothelial Function
Principal investigator · Completed · Phase 1
Stanford University